Advances in the systemic treatment of therapeutic approaches in biliary tract cancer
Mirallas, O., López-Valbuena, D., García-Illescas, D., Fabregat-Franco, C., Verdaguer, H., Tabernero, J., Macarulla, T.
Published in ESMO open (01.06.2022)
Published in ESMO open (01.06.2022)
Get full text
Journal Article
Immune prognostic index (IPI) and hyper-progressive disease (HPD) in patients (pts) exposed to targeted agents (TAs) in phase I trials (Ph1T): Can lessons from immune checkpoint inhibitors (ICIs) be translated to other scenarios?
Matos Garcia, I., Azaro, A., Viaplana, C., Hierro, C., Martin-Liberal, J., Brana, I., Gardeazabal, I., Gomila, P., Vieito Villar, M., Ochoa De Olza Amat, M., Elez Fernandez, E., Oliveira, M., Oaknin, A., Verdaguer, H., Navarro Mendivil, A., Alsina, M., Tabernero, J., Macarulla Mercade, T., Dienstmann, R., Garralda, E.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Neoadjuvant therapy for borderline resectable pancreatic adenocarcinoma. Preliminary results
Busquets, J, Peláez, N, Laquente, B, Verdaguer, H, Secanella, L, Rafecas, A, Torras, J, Serrano, T, Ruiz, S, Ramos, E, Fabregat, J
Published in Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] (01.06.2015)
Published in Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] (01.06.2015)
Get full text
Journal Article
61P Clinical and molecular characterisation of IDH1/2 mutant cholangiocarcinoma
Castet, F., Serra Camprubí, Q., Fabregat-Franco, C., Verdaguer, H., Castillo, G., Tian, T., Macarulla, T.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
1689P Adverse event management during treatment with bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1: Treatment guidelines based on experience in clinical trials
Gulley, J., Lacouture, M.E., Spira, A., Mata, H. Verdaguer, Yoo, C., Cho, B.C., Helwig, C., Halady, T., Valencia, C., Bajars, M., Strauss, J., Brownell, I.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
O-2 Phase III study of NUC-1031 + cisplatin vs gemcitabine + cisplatin for first-line treatment of patients with advanced biliary tract cancer (NuTide:121)
Knox, J., Bazin, I., Oh, D., Zubkov, O., Breder, V., Bai, L., Christie, A., McNamara, M., Goyal, L., Cosgrove, D., Springfeld, C., Sjoquist, K., Park, J., Verdaguer, H., Braconi, C., Ross, P., de Gramont, A., Shroff, R., Zalcberg, J., Palmer, D., Valle, J.
Published in Annals of oncology (01.06.2023)
Published in Annals of oncology (01.06.2023)
Get full text
Journal Article
59TiP Phase III study of NUC-1031 + cisplatin vs gemcitabine + cisplatin for first-line treatment of patients with advanced biliary tract cancer (NuTide:121)
Knox, J., McNamara, M.G., Goyal, L., Cosgrove, D., Springfeld, C., Sjoquist, K., Park, J.O., Verdaguer, H., Braconi, C., Ross, P., Oh, D-Y., De Gramont, A., Shroff, R.T., Zalcberg, J.R., Palmer, D., Valle, J.W.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
1549P Molecular alterations (MA) with potential therapeutic implications in KRAS wild-type (WT) pancreatic cancer patients
Acosta Eyzaguirre, D.A., Verdaguer, H., Buxò, E., Garcia-Alvarez, A., Sardo, E., Hernando, J., Diez Garcia, M., Guardiola, M., Ros Montañá, F.J., Baraibar Argota, I., Saoudi, N., Marmolejo Castaneda, D.H., Aguilar, S., Sierra, A., Vivancos, A., Dienstmann, R., Macarulla Mercadé, T.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
80TiP Global phase III study of NUC-1031 plus cisplatin vs gemcitabine plus cisplatin for first-line treatment of patients with advanced biliary tract cancer (NuTide:121)
Knox, J.J., McNamara, M.G., Goyal, L., Doherty, M., Cosgrove, D., Springfeld, C., Sjoquist, K., Park, J.O., Verdaguer, H., Braconi, C., Ross, P., De Gramont, A., Zalcberg, J.R., Palmer, D., Valle, J.W.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
6P Circulating tumor DNA (ctDNA) next generation sequencing (NGS): Molecular prescreening for tailoring treatment in clinical trials
Alonso, G., Aguilar, S., Ros Montana, F.J., Verdaguer, H., Callejo Perez, A., Brana, I., Baraibar Argota, I., Iranzo Gomez, P., Saavedra Santa Gadea, O., Salva Ballabrera, F., Acosta Eyzaguirre, D.A., Vieito Villar, M., Garcia Torralba, E., Wornham, N.A., Faull, I., Tabernero, J., Felip, E., Elez, E., Macarulla Mercade, T., Garralda, E.
Published in Annals of oncology (01.10.2021)
Published in Annals of oncology (01.10.2021)
Get full text
Journal Article
1925P DNA methylation signature for prediction of metastasis and response to multikinase inhibitors of differentiated thyroid carcinoma (DTC)
Hernando, J., Zafon, C., Diez-Villanueva, A., Iglesias, C., Rodriguez, H., Villalmazo, N., Gil, J., Klein-Hesselink, E., Roca, M., Verdaguer, H., Acosta Eyzaguirre, D.A., Diez Garcia, M., Lindo, E., Hernandez-Losa, J., Reverter, J., Puig-Domingo, M., Links, T., Capdevila, J., Jordà, M.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
573P Efficacy of immunotherapy (IT) after prior immune checkpoint inhibitors (ICIs) exposure
Hernando-Calvo, A., Valdivia, A., Santa Gadea, O. Saavedra, Braña, I., Berché, R., Matos, I., Vieito, M., Pedrazzoli, A.B. Azaro, Casal, G. Alonso, Galvão, V., Garcia, M. Diez, Verdaguer, H., Velez, C. Ortiz, Gonzalez, M., Argota, I. Baraibar, Callejo, A., Couselo, E. Munoz, Tabernero, J., Dienstmann, R., Garralda, E.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
1558P Pancreatic cancer (PC) in patients (pts) younger than 50 years: Clinical outcomes and actionable genomic/genetic alterations
Garcia-Alvarez, A., Verdaguer, H., Guardiola, M., Acosta Eyzaguirre, D.A., Buxò, E., Sardo, E., Saoudi, N., Marmolejo Castaneda, D.H., Hernando, J., Diez Garcia, M., Baraibar Argota, I., Ros Montañá, F.J., Sierra, A., Molero, C., Miquel, J.M., Vivancos, A., Dienstmann, R., Macarulla Mercadé, T.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
1545P DNA damage repair (DDR) gene mutations (mut) are predictors of response to platinum-based chemotherapy in advanced pancreatic cancer (PC) patients (pts)
Verdaguer, H., Guardiola, M., Mancuso, F.M., Acosta Eyzaguirre, D.A., Buxò, E., Hernando, J., Diez Garcia, M., Laquente, B., Baraibar Argota, I., Ros Montañá, F.J., Garcia-Alvarez, A., Matito, J., Martin, A., Sierra, A., Villacampa Javierre, G., Molero, C., Miquel, J.M., Vivancos, A., Dienstmann, R., Macarulla Mercadé, T.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
110PImmune prognostic index (IPI) and hyper-progressive disease (HPD) in patients (pts) exposed to targeted agents (TAs) in phase I trials (Ph1T): Can lessons from immune checkpoint inhibitors (ICIs) be translated to other scenarios?
Matos Garcia, I, Azaro, A, Viaplana, C, Hierro, C, Martin-Liberal, J, Brana, I, Gardeazabal, I, Gomila, P, Vieito Villar, M, Ochoa De Olza Amat, M, Elez Fernandez, E, Oliveira, M, Oaknin, A, Verdaguer, H, Navarro Mendivil, A, Alsina, M, Tabernero, J, Macarulla Mercade, T, Dienstmann, R, Garralda, E
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Molecular, clinical and prognostic characterization of double KRAS/PIK3CA (dKP) mutated metastatic colorectal cancer (mCRC)
Grasselli, J., Elez, E., Martinez, G. Argiles, Sanz-Garcia, E., Macarulla, T., Capdevila, J., Alsina, M., Sauri, T., Hierro, C., Verdaguer, H., Matos, I., Garcia, A., Nuciforo, P., Landolfi, S., Palmer, H. Garcia, Dienstmann, R., Vivancos, A., Tabernero, J.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
Prognostic impact of KRAS mutation in metastatic (met) pancreatic cancer patients (pts)
Verdaguer, H., Sauri, T., Ruiz, F., Vivancos, A., Nuciforo, P., Capdevila, J., Elez, E., Alsina, M., Martinez, G. Argiles, Hierro, C., Grasselli, J., Matos, I., Tabernero, J., Dienstmann, R., Macarulla, T.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
51P Toxicity profile in early clinical trials with fibroblast growth factor receptor (FGFR) inhibitors (FGFRi): 10-years experience of a drug development unit
Rojas Laimito, K.I., Vieito Villar, M., Fullana Grimalt, B., Berché, R., Hierro Carbo, C., Saavedra Santa Gadea, O., Braña, I., Alonso Casal, G., Galvao de Aguiar, V., Lostes Bardaji, M.J., Oliveira, M., Verdaguer, H., Morales Barrera, R., Garcia Duran, C., Zamora, E., Carles Galceran, J., Macarulla, T., Tabernero, J., Garralda Cabanas, E.
Published in ESMO open (01.03.2023)
Published in ESMO open (01.03.2023)
Get full text
Journal Article
P-183 Neoadjuvant treatment in borderline resectable pancreatic adenocarcinoma (PA): A single center series
Verdaguer Mata, H., Laquente, B., Busquets, J., Pelaez, N., Secanella, L., Leiva, D., Ruiz, S., Peiro, I., Lopez Urdiales, R., Serrano, T., Vazquez, S., Calvo, M., Serra, O., Cambray, M., Perez Martin, F.J., Sanchez, C., Galan, M., Fabregat, J.
Published in Annals of oncology (01.06.2015)
Published in Annals of oncology (01.06.2015)
Get full text
Journal Article